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Abstract: Recently, we reported the discovery of a dromedary camel coronavirus UAE-HKU23
(DcCoV UAE-HKU23) from dromedaries in the Middle East. In this study, DcCoV UAE-HKU23 was
successfully isolated in two of the 14 dromedary fecal samples using HRT-18G cells, with cytopathic
effects observed five days after inoculation. Northern blot analysis revealed at least seven distinct
RNA species, corresponding to predicted subgenomic mRNAs and confirming the core sequence of
transcription regulatory sequence motifs as 51-UCUAAAC-31 as we predicted previously. Antibodies
against DcCoV UAE-HKU23 were detected in 58 (98.3%) and 59 (100%) of the 59 dromedary sera
by immunofluorescence and neutralization antibody tests, respectively. There was significant
correlation between the antibody titers determined by immunofluorescence and neutralization assays
(Pearson coefficient = 0.525, p < 0.0001). Immunization of mice using recombinant N proteins of
DcCoV UAE-HKU23 and Middle East respiratory syndrome coronavirus (MERS-CoV), respectively,
and heat-inactivated DcCoV UAE-HKU23 showed minimal cross-antigenicity between DcCoV
UAE-HKU23 and MERS-CoV by Western blot and neutralization antibody assays. Codon usage and
genetic distance analysis of RdRp, S and N genes showed that the 14 strains of DcCoV UAE-HKU23
formed a distinct cluster, separated from those of other closely related members of Betacoronavirus 1,
including alpaca CoV, confirming that DcCoV UAE-HKU23 is a novel member of Betacoronavirus 1.
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1. Introduction
Coronaviruses (CoVs) are found in a wide variety of animals [1] in which they can cause
respiratory, enteric, hepatic, and neurological diseases. Based on genotypic and serological
characterization, CoVs were traditionally classified into three distinct groups [2–4]. Recently, the
Coronavirus Study Group of the International Committee for Taxonomy of Viruses has replaced
the traditional groups 1, 2, and 3 CoVs with three genera, Alphacoronavirus, Betacoronavirus, and
Gammacoronavirus, respectively [5]. As a result of their unique mechanism of viral replication, CoVs
have a high frequency of recombination [2,6]. Their tendency for recombination and high mutation
rates may allow them to adapt to new hosts and ecological niches [7–10].
In 2003, the severe acute respiratory syndrome (SARS) epidemic, discovery of SARS-CoV, and
identification of SARS-CoV-like viruses from Himalayan palm civets from wild live markets in China
boosted interest in the discovery of novel CoVs in humans and animals [11–16]. A novel human CoV
(HCoV) of the genus Alphacoronavirus, human CoV NL63 (HCoV-NL63), was reported in 2004 [17–19].
In 2005, we also described the discovery, complete genome sequence, and molecular epidemiology
of another novel HCoV, human CoV HKU1 (HCoV-HKU1), in the genus Betacoronavirus [20–22].
As for animal CoVs, we and others have described the discovery of SARS-CoV-like viruses in
Chinese horseshoe bats in Hong Kong and other horseshoe bats in other provinces of China [23,24].
Recently, the discovery of SARS-CoV-like viruses in Chinese horseshoe bats in Yunnan has further
highlighted the importance for hunting the animal origin of human infections [25]. In addition, we
have also discovered 21 other animal CoVs, which include two novel lineages in Betacoronavirus
and a novel genus Deltacoronavirus [26–36]. From our studies it was shown that bats are the gene
source for Alphacoronavirus and Betacoronavirus and birds are the gene source for Gammacoronavirus
and Deltacoronavirus to fuel CoV evolution and dissemination [33].
In 2012, a novel CoV, named Middle East respiratory syndrome coronavirus (MERS-CoV), closely
related to Tylonycteris bat CoV HKU4 (Ty-BatCoV HKU4) and Pipistrellus bat CoV HKU5 (Pi-BatCoV
HKU5), has emerged as a cause of severe respiratory infections associated with high mortalities [37–40].
It has been shown that dromedaries in the Middle East possessed neutralizing antibodies against
MERS-CoV [41,42]. Furthermore, MERS-CoV was also detected in the nasal swabs of dromedaries
in Qatar, Saudi Arabia, Egypt, and the United Arab Emirates [43–47]. The recent emergence of
MERS and the discovery of MERS-CoV in dromedaries have boosted interest in the search for other
novel viruses in dromedaries [48,49]. In a recent molecular epidemiology study, we discovered a
novel betacoronavirus, named dromedary camel CoV UAE-HKU23 (DcCoV UAE-HKU23), from fecal
samples of dromedaries from Dubai [50]. In this study, we report the isolation of DcCoV UAE-HKU23
from the fecal sample of a dromedary and its characterization.
2. Results
2.1. Isolation of DcCoV UAE-HKU23
Of the seven cell lines inoculated with dromedary fecal samples positive for DcCoV UAE-HKU23,
viral replication was detected by RT-PCR in the supernatants of HRT-18G in two of the 14 dromedary
fecal samples at day 7, with viral loads of 2.6 ˆ 1010 and 9.7 ˆ 106 copies/mL in HRT-18G cells in the
presence of trypsin. Cytopathic effects (CPE), mainly in the form of rounded, fused and granulated
giant cells rapidly detaching from the monolayer, were also observed in infected HRT-18G cells five
days after inoculation (Figure 1a), which showed viral nucleocapsid expression by immunofluorescence
in 20% of cells. Electron microscopy of ultracentrifuged cell culture extracts from infected HRT-18G
cells showed the presence of CoV-like particles around 70–100 nm in diameter with typical club-shaped
surface projections (Figure 1b).
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Figure 1. (a) HRT-18G cells infected with dromedary camel coronavirus (DcCoV) UAE-HKU23 
showing cytopathic effects with rounded, aggregated, fused, and granulated giant cells rapidly 
detaching from the monolayer at day 5 after incubation (arrows) (original magnification 40×);  
(b) Negative contrast electron microscopy of ultracentrifuged deposit of HRT-18G cell culture-grown 
DcCoV UAE-HKU23, showing typical club-shaped surface projections (arrow) of coronavirus 
particles, with rabbit coronavirus HKU14 as the control (bottom left corner). Bar = 50 nm; Indirect 
immunofluorescent antigen detection in (c) uninfected and (d) infected HRT-18G cells using serum 
from dromedary showing apple green fluorescence in (arrows) DcCoV UAE-HKU23 infected  
HRT-18G cells (original magnification 100× for both). 
2.2. Subgenomic mRNAs and Their Leader-Body Junction Sequences 
CoVs are characterized by a unique mechanism of discontinuous transcription with the 
synthesis of a nested set of subgenomic mRNAs [51,52]. To assess the number and size of DcCoV 
UAE-HKU23 subgenomic mRNA species, Northern blot analysis with a probe specific to the 
nucleocapsid sequence was performed. At least seven distinct RNA species were identified, with the 
sizes corresponding to predicted subgenomic mRNAs of NS2 (~9600 bp), hemagglutinin-esterase (HE) 
(~8760 bp), spike (S) (~7460 bp), NS5 (~3040 bp), envelope (E) (~2800 bp), membrane (M) (~2410 bp) 
and nucleocapsid (N) (~1710 bp) (Figure 2a). 
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Figure 1. (a) HRT-18G cells infected with dromedary camel coronavirus (DcCoV) UAE-HKU23 showing
cytopathic effects with rounded, aggregated, fused, and granulated giant cells rapidly detaching
from the monolayer at day 5 after incubation (arrows) (original magnification 40ˆ); (b) Negative
contrast electron microscopy of ultracentrifuged deposit of HRT-18G cell culture-grown DcCoV
UAE-HKU23, showing typical club-shaped surface projections (arrow) of coronavirus particles, with
rabbit coronavirus HKU14 as the control (bottom left corner). Bar = 50 nm; Indirect immunofluorescent
antigen detection in (c) uninfected and (d) infected HRT-18G cells using serum from dromedary
showing apple green fluorescence in (arrows) DcCoV UAE-HKU23 infected HRT-18G cells (original
magnification 100ˆ for both).
2.2. Subgenomic mRNAs and Their Leader-Body Junction Sequences
CoVs are characterized by a unique mechanism of discontinuous transcription with the synthesis
of a nested set of subgenomic mRNAs [51,52]. To assess the number and size of DcCoV UAE-HKU23
subgen mic mRNA species, No thern blot an ly is with a probe specifi to th nucleocapsid sequence
was perf rmed. At least s ven distinct RNA species were identified, with the sizes corresponding to
predicted subgenomic mRNAs of NS2 (~9600 bp), hemagglutinin-esterase (HE) (~8760 bp), spike (S)
(~7460 bp), NS5 (~3040 bp), envelope (E) (~2800 bp), membrane (M) (~2410 bp) and nucleocapsid (N)
(~1710 bp) (Figure 2a).
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Figure 2. (a) Northern blot analysis for total RNA isolated from dromedary camel coronavirus 
(DcCoV) UAE-HKU23–infected HRT-18G cells. RNA species are indicated by arrows. NS2,  
non-structural NS2; HE, hemagglutinin; S, spike; NS5, non-structural NS5; E, envelope; M, 
membrane; N, nucleocapsid. Lane 1, 1 μg total RNA from uninfected cells; Lane 2, 1 μg total RNA 
from infected cells; (b) DcCoV UAE-HKU23 subgenomic mRNA (sg mRNA) leader-body junction 
and flanking sequences. The subgenomic mRNA sequences are shown in alignment with the leader 
and the genomic sequences. The start codon AUG in each subgenomic mRNA is depicted in bold. The 
putative transcription regulatory sequences (TRS) was underlined and base mismatch between the 
body TRS and the leader TRS or the corresponding genomic region was indicated by asterisk. The 
43N and 115N in the parentheses indicate that 43 and 115 nucleotides at that region are not shown. 
By determining the leader-body junction sequences of subgenomic mRNAs from DcCoV  
UAE-HKU23–infected cell cultures, the subgenomic mRNA sequences were aligned to the leader 
sequence which confirmed the core sequence of the transcription regulatory sequences (TRS) motifs 
as 5′-UCUAAAC-3′ (Figure 2b), as in other Betacoronavirus lineage A CoVs [53–56]. The leader TRS 
and subgenomic mRNA of NS2, HE, S, and N exactly matched each other, whereas there was one 
base mismatch for NS5, E, and M. These results are in line with our previous prediction on the  
TRS [50]. The DcCoV UAE-HKU23 common leader on subgenomic mRNAs was confirmed as the 
first 65 nucleotides of the DcCoV UAE-HKU23 genome. 
2.3. Immunofluorescence Antibody Tests and Neutralization Antibody Assays 
Fifty-nine serum samples from dromedaries were subject to immunofluorescence and 
neutralization antibody assays for DcCoV UAE-HKU23. Results were positive in 58 (98.3%) and 59 
(100%) of the 59 samples as detected by immunofluorescence and the neutralization antibody test, 
respectively (Table 1; Figure 1c,d). In addition, there was significant correlation between the titers 
determined by the immunofluorescence antibody test and the neutralization antibody assay (Pearson 
coefficient = 0.525, p < 0.0001) (Figure 3). 
Figure 2. (a) Northern blot analysis for total RNA isolated from dromedary camel coronavirus (DcCoV)
UAE-HKU23–infected HRT-18G cells. RNA species are indicated by arrows. NS2, non-structural NS2;
HE, hemagglutinin; S, spike; NS5, non-structural NS5; E, envelope; M, membrane; N, nucleocapsid.
Lane 1, 1 µg total RNA from uninfected cells; Lane 2, 1 µg total RNA from infected cells; (b) DcCoV
UAE-HKU23 subgenomic mRNA (sg mRNA) leader-body junction and flanking sequences. The
subgenomic mRNA sequences are shown in alignment with the leader and the genomic sequences. The
start codon AUG in each subgenomic mRNA is depicted in bold. The putative transcription regulatory
sequences (TRS) was underlined and base mismatch between the body TRS and the leader TRS or
the corresponding genomic region was indicated by asterisk. The 43N and 115N in the parentheses
indicate that 43 and 115 nucleotides at that region are not shown.
By determining the leader-body junction sequences of subgenomic mRNAs from DcCoV
UAE-HKU23–infected cell cultures, the subgenomic mRNA sequences were aligned to the leader
sequence which confirmed the core sequence of the transcription regulatory sequences (TRS) motifs as
51-UCUAAAC-31 (Figure 2b), as in other Betacoronavirus lineage A CoVs [53–56]. The leader TRS and
subgenomic mRNA of NS2, HE, S, and N exactly matched each other, whereas there was one base
mismatch for NS5, E, and M. These results are in line with our previous prediction on the TRS [50]. The
DcCoV UAE-HKU23 common leader on subgenomic mRNAs was confirmed as the first 65 nucleotides
of the DcCoV UAE-HKU23 genome.
2.3. Immunofluorescence Antibody Tests and Neutralization Antibody Assays
Fifty-nine serum samples from dromedaries were subject to immunofluorescence and
neutralization antibody assays for DcCoV UAE-HKU23. Results were positive in 58 (98.3%) and
59 (100%) of the 59 samples as detected by immunofluorescence and the neutralization antibody test,
respectively (Table 1; Figure 1c,d). In addition, there was significant correlation between the titers
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coefficient = 0.525, p < 0.0001) (Figure 3).Int. J. Mol. Sci. 2016, 17, 691 5 of 19 
 
 
Figure 3. Comparison of neutralization antibody titer and immunofluorescence antibody titer of 
dromedary serum samples for dromedary camel coronavirus UAE-HKU23. Numbers of serum 
samples with that particular neutralization antibody and immunofluorescence antibody titers are 
indicated by points with different colors. 
Table 1. Dromedary camel coronavirus UAE-HKU23 antibody detection by immunofluorescence and 
neutralization antibody tests. 
Antibody Titer Number (%) of Samples
Immunofluorescence Antibody Test
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320 23 (39.0) 
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2.4. Cross-Antigenicity between DcCoV UAE-HKU23 and MERS-CoV 
To examine possible cross-antigenicity between the DcCoV UAE-HKU23 and MERS-CoV N 
proteins, recombinant N proteins of DcCoV UAE-HKU23 and MERS-CoV were cloned and purified 
and tested against serum samples of balb/c mice immunized with the N proteins of DcCoV  
UAE-HKU23 and MERS-CoV, respectively. The highest dilutions of the serum, obtained from the 
mouse immunized with the DcCoV UAE-HKU23 N protein, which generated immunoreactive bands 
in the Western blot assay, were 1:64,000 and 1:2000, respectively, when the DcCoV UAE-HKU23 N 
Figure 3. Comparison of neutralization antibody titer and immunofluorescence antibody titer of
dromedary serum samples for dromedary camel coronavirus UAE-HKU23. Numbers of serum samples
with that particular neutralization antibody and immunofluorescence antibody titers are indicated by
points with different colors.
Table 1. Dromedary camel coronavirus UAE-HKU23 antibody detection by immunofluorescence and
neutralization antibody tests.
Antibody Titer Number (%) of Samples
Immunofluorescence Antibody Test
<20 1 (1.7)
80 21 (35.6)
320 23 (39.0)
1280 13 (22.0)
5120 1 (1.7)
Neutralization Antibody Test
10 2 (3.4)
20 4 (6.8)
40 6 (10.2)
80 18 (30.5)
160 11 (18.6)
320 9 (15.3)
640 5 (8.5)
1280 2 (3.4)
2560 2 (3.4)
2.4. Cross-Antigenicity between DcCoV UAE-HKU23 and MERS-CoV
To examine possible cross-antigenicity between the DcCoV UAE-HKU23 and MERS-CoV N
proteins, recombinant N proteins of DcCoV UAE-HKU23 and MERS-CoV were cloned and purified and
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tested against serum samples of balb/c mice immunized with the N proteins of DcCoV UAE-HKU23
and MERS-CoV, respectively. The highest dilutions of the serum, obtained from the mouse immunized
with the DcCoV UAE-HKU23 N protein, which generated immunoreactive bands in the Western
blot assay, were 1:64,000 and 1:2000, respectively, when the DcCoV UAE-HKU23 N protein and
MERS-CoV N protein were used as the antigens, respectively (Figure 4). The highest dilutions of
the serum, obtained from the mouse immunized with the MERS-CoV N protein, which generated
immunoreactive bands in the Western blot assay, were 1:512,000 and 1:8000, respectively, when the
MERS-CoV N protein and DcCoV UAE-HKU23 N protein were used as the antigens, respectively
(Figure 4).
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reacted with 1:16,000 dilution of serum from mouse immunized with MERS-CoV N protein, Lane 4: 
DcCoV UAE-HKU23 N protein reacted with 1:16,000 dilution of serum from mouse immunized with 
DcCoV UAE-HKU23 N protein. 
To further examine possible cross-antigenicity between DcCoV UAE-HKU23 and MERS-CoV, 
heat-inactivated DcCoV UAE-HKU23 was used for immunization of balb/c mice and the serum 
obtained was tested for neutralization antibodies against DcCoV UAE-HKU23 and MERS-CoV, 
respectively. Neutralization antibody assays showed that the neutralization antibody titer of the 
pooled serum sample was 1:160 for DcCoV UAE-HKU23 but <1:20 for MERS-CoV. 
2.5. Complete RdRp, S and N Gene Sequence Analysis 
To determine the number of genotypes/circulating strains of DcCoV UAE-HKU23, the complete 
RNA-dependent RNA polymerase (RdRp), S, and N genes of 11 additional DcCoV UAE-HKU23 
strains from dromedary fecal samples positive for DcCoV UAE-HKU23 were sequenced. For the 
RdRp and N genes, all these 11 DcCoV UAE-HKU23 strains together with those of the three DcCoV 
UAE-HKU23 strains with complete genome sequences [50] possessed identical amino acid sequences, 
although there were 0–2 nucleotide differences among the strains for both genes (Figure 5). As for 
the S gene, phylogenetic analysis using either nucleotide or amino acid sequences revealed two 
clusters (Figure 5). There were 10 nucleotide differences among the two groups. Five were 
synonymous substitutions, and the other five resulted in amino acid changes (V105A, S436A, L845V, 
S967P, and P1188S). 
2.6. Codon Usage Analysis and Genetic Distance of RdRp, S and N Genes 
By corresponding analysis (CA) on relative synonymous codon usage (RSCU) values, patterns 
in codon usage were observed that allowed different groups in Betacoronavirus 1 to be distinguished. 
The RdRp, S, and N genes of the 14 strains of DcCoV UAE-HKU23 formed a distinct cluster, separated 
from those of other closely related members of Betacoronavirus 1, including alpaca CoV (DQ915164) 
Figure 4. Western blotting analysis of dromedary camel coronavirus (DcCoV) UAE-HKU23 and Middle
East respiratory syndrome coronavirus (MERS-CoV) N proteins expressed in E. coli. Lane 1: MERS-CoV
N protein reacted with 1:16,000 dilution of serum from mouse immunized with MERS-CoV N protein;
Lane 2: MERS-CoV N protein reacted with 1:16,000 dilution of serum from mouse immunized with
DcCoV UAE-HKU23 N protein; Lane 3: DcCoV UAE-HKU23 N protein reacted with 1:16,000 dilution
of serum from mouse immunized with MERS-CoV N protein, Lane 4: DcCoV UAE-HKU23 N protein
reacted with 1:16,000 dilution of serum from mouse immunized with DcCoV UAE-HKU23 N protein.
To further examine possible cross-antigenicity between DcCoV UAE-HKU23 and MERS-CoV,
heat-inactivated DcCoV UAE-HKU23 was used for immunization of balb/c mice and the serum
obtained was tested for neutralization antibodies against DcCoV UAE-HKU23 and MERS-CoV,
respectively. Neutralization antibody assays showed that the neutralization antibody titer of the
pooled serum sample was 1:160 for DcCoV UAE-HKU23 but <1:20 for MERS-CoV.
2.5. Complete RdRp, S and N Gene Sequence Analysis
To determine the number of genotypes/circulating strains of DcCoV UAE-HKU23, the complete
RNA-dependent RNA polymerase (RdRp), S, and N genes of 11 additional DcCoV UAE-HKU23 strains
from dromedary fecal samples positive for DcCoV UAE-HKU23 were sequenced. For the RdRp and N
genes, all these 11 DcCoV UAE-HKU23 strains together with those of the three DcCoV UAE-HKU23
strains with complete genome sequences [50] possessed identical amino acid sequences, although
there were 0–2 nucleotide differences among the strains for both genes (Figure 5). As for the S gene,
phylogenetic analysis using either nucleotide or amino acid sequences revealed two clusters (Figure 5).
There were 10 nucleotide differences among the two groups. Five were synonymous substitutions,
and the other five resulted in amino acid changes (V105A, S436A, L845V, S967P, and P1188S).
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2.6. Codon Usage Analysis and Genetic Distance of RdRp, S and N Genes
By corresponding analysis (CA) on relative synonymous codon usage (RSCU) values, patterns in
codon usage were observed that allowed different groups in Betacoronavirus 1 to be distinguished. The
RdRp, S, and N genes of the 14 strains of DcCoV UAE-HKU23 formed a distinct cluster, separated
from those of other closely related members of Betacoronavirus 1, including alpaca CoV (DQ915164)
(Figure 6a) [57]. Analysis of the nucleotide sequence corresponding to the RdRp, S, and N genes
showed that alpaca CoV has a lower genetic distance to bovine CoV (BCoV) and other recently isolated
wild ruminant CoVs than to DcCoV UAE-HKU23 (Figure 6b).
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1347 nucleotide positions in RdRp, S and N, respectively. For RdRp, the scale bar indicates the 
estimated number of substitutions per 200 nucleotides. For S, the scale bars indicate the estimated 
number of substitutions per 50 nucleotides. For N, the scale bars indicate the estimated number of 
substitutions per 100 nucleotides. Bootstrap values were calculated from 1000 trees and those below 
70% are not shown. The 14 strains of DcCoV UAE-HKU23 characterized in this and our previous 
studies are shown in bold. BCoV, bovine coronavirus; CRCoV, canine respiratory coronavirus; 
SDCoV, sambar deer coronavirus; WbCoV, waterbuck coronavirus; WtDCoV, white-tailed deer 
coronavirus; BRCoV, bovine respiratory coronavirus; GiCoV, giraffe coronavirus; SACoV, sable 
antelope coronavirus. 
Figure 5. Phylogenetic analyses of RNA-dependent RNA polymerase (RdRp), S, and N genes of
dromedary camel coronavirus (DcCoV) UAE-HKU23. Included in the analysis were 2784, 4101, and
1347 nucleotide positions in RdRp, S and N, respectively. For RdRp, the scale bar indicates the estimated
number of substitutions per 200 nucleotides. For S, the scale bars indicate the estimated number of
substitutions per 50 nucleotides. For N, the scale bars indicate the estimated number of substitutions
per 100 nucleotides. Bootstrap values were calculated from 1000 trees and those below 70% are not
shown. The 14 strains of DcCoV UAE-HKU23 characterized in this and our previous studies are
shown in bold. BCoV, bovine coronavirus; CRCoV, canine respiratory coronavirus; SDCoV, sambar
deer coronavirus; WbCoV, waterbuck coronavirus; WtDCoV, white-tailed deer coronavirus; BRCoV,
bovine respiratory coronavirus; GiCoV, giraffe coronavirus; SACoV, sable antelope coronavirus.
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Figure 6. (a) Scatter plot of the corresponding analysis (CA) using relative synonymous codon usage
(RSCU) of the RdRp, S, and N genes of members of Betacoronavirus 1 and RbCoV HKU14. Different
coronaviruses are indicated in different colored markers. The group of bovine coronavirus-like viruses
is circled; (b) SimPlot analysis of complete RdRp, S, and N genes of DcCoV UAE-HKU23, alpaca CoV,
BCoV and other wild ruminant CoVs. Each point plotted is the percent genetic distance within a sliding
indow of 200 nt wide, centered on the position plotted, with a step size of 20 nt. Each curve represents
a comparison of the sequence data of DcCoV UAE-HKU23, B o , and other wild ruminant CoV
strains to the reference sequence data of alpaca CoV. Alpaca CoV, al aca coronavirus; B o , bovine
c r a ir s; uCoV, Bubalus bubalis coronavirus; CRCoV, canine respiratory coronavirus; DcCoV,
dromedar camel coronavirus, ECoV, equine coronavirus; GiCoV, giraff coronavirus; HCoV-OC43,
human coronavirus O 43; HTCoV, Himalayan tahr coronavirus; NyCoV, ny la coronavirus; PHEV,
porcine hemaggluti ting encephalomyelitis virus; RbCoV, rabbit coronavirus; SACoV, sable antelope
; SDCoV, sambar deer coronavir s; iCoV, sitatunga co onavirus; WbCoV, wa erbuck
iCoV, wisent coronavirus; WtDCoV, white-tailed deer coronavirus.
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3. Discussion
In this study, we have successfully isolated DcCoV UAE-HKU23 using the HRT-18G cell line.
With only a few exceptions, such as SARS-CoV and MERS-CoV, CoVs are notoriously difficult to
isolate in cell lines [58,59]. For the HCoVs OC43 and 229E, they induce only subtle CPEs, even if
isolated. In our previous report on the discovery of DcCoV UAE-HKU23 from fecal samples of
dromedaries by RT-PCR, no positive culture results were obtained from any of the three samples used
for complete genome sequencing [50]. In the present study, after inoculation of all 14 fecal samples
that were RT-PCR–positive for DcCoV UAE-HKU23, the virus was successfully isolated from two of
the 14 samples using HRT-18G cells, with rounding and fusion to giant cells rapidly detaching from
the monolayer. Northern blot experiments and determination of leader-body junction sequences of
subgenomic mRNAs confirmed our previous predictions on the open reading frames (ORFs) and TRS
of DcCoV UAE-HKU23 by comparison to other CoVs of Betacoronavirus 1 [50]. Although sequencing of
the RdRp, S, and N genes showed that there were two or more strains circulating in the dromedaries,
no obvious genotypes were observed for the 14 strains of DcCoV UAE-HKU23 in this study. Since
HCoV-OC43, BCoV [60], equine CoV, alpaca CoV, the murine hepatitis virus-H2 variant, our recently
discovered rabbit CoV (RbCoV) HKU14 [34], and DcCoV UAE-HKU23 can all replicate in HRT-18G
cells, it suggests that these CoVs that belonged to Betacoronavirus lineage A (the traditional “group
2 CoVs”) may share similar cellular tropisms. The HRT-18G cell line could be used to isolate other
members of Betacoronavirus lineage A for further characterization of these CoVs.
Although DcCoV UAE-HKU23 and alpaca CoV are both isolated from camelids, they represent
two distinct CoVs. Camelids (family Camelidae) are classified into the old world camels (genus
Camelus), including dromedaries and Bactrians, and the new world camels (genera Lama and Vicugna),
including llama, guanaco, alpaca, and vicuna. Since the alpaca CoV, which infects alpaca, and DcCoV
UAE-HKU23, which infects dromedaries, are both members of Betacoronavirus 1, it raised the question
whether alpaca CoV and DcCoV UAE-HKU23 are the same or different CoVs. We therefore analyzed
the codon usage bias in the RdRp, S, and N genes of these two viruses. Results showed distinct
codon usage bias and genetic distance for alpaca CoV and DcCoV UAE-HKU23. In fact, alpaca CoV
showed much more similar codon usage bias and lower genetic distance to BCoV and other wild
ruminant CoVs including water buffalo CoV, giraffe CoV, Himalayan tahr CoV, nyala CoV, sable
antelope CoV, sambar deer CoV, sitatunga CoV, waterbuck CoV, wisent CoV, and white-tailed deer
CoV than to DcCoV UAE-HKU23 in the RdRp, S, and N genes (Figure 6) [10,61–64]. In addition
to codon usage and genetic distance, the S protein of DcCoV UAE-HKU23 contains one additional
potential N-glycosylation site at amino acid position 492 compared to alpaca CoV (data not shown).
This potential N-glycosylation site is also present in the S proteins of canine respiratory coronavirus
and HCoV-OC43, but not in those of other wild ruminant CoVs. All these indicated that alpaca CoV
and DcCoV UAE-HKU23 are two different CoVs adapting to two different hosts residing in two
different geographical locations (alpaca in South America and dromedaries in the Middle East and
North Africa) in the world.
Minimal cross-antigenicity was observed between the N proteins of DcCoV UAE-HKU23 and
MERS-CoV. In our study on genotyping and serological characterization of Rousettus bat CoV HKU9
(Ro-BatCoV HKU9), we have shown that there is minimal serological cross-reactivity among the
four lineages of betacoronaviruses using human serum samples positive for antibodies against the
N protein of HCoV-HKU1 (lineage A), Chinese horseshoe bat serum samples positive for antibodies
against the N protein of SARSr-Rh-BatCoV (lineage B), and Leschenault’s rousette bat serum samples
positive for antibodies against the N protein of Ro-BatCoV HKU9 (lineage D), and against recombinant
N proteins of HCoV-HKU1 (lineage A), SARSr-Rh-BatCoV (lineage B), Ty-BatCoV HKU4 (lineage
C), Pi-BatCoV HKU5 (lineage C), and Ro-BatCoV HKU9 (lineage D) [31]. In our recent study on the
discovery of DcCoV UAE-HKU23, the serological data further showed little cross-reactivity between
DcCoV UAE-HKU23 (lineage A) and SARSr-Rh-BatCoV (lineage B), Pi-BatCoV HKU5 (lineage C), and
Ro-BatCoV HKU9 (lineage D), respectively, using dromedary serum samples positive for antibodies
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against the N protein of DcCoV UAE-HKU23 [50]. In the present study, we showed that the antibody
titer of the serum obtained from the mouse immunized with the recombinant N protein of MERS-CoV
for the anti-N of MERS-CoV was 64 folds higher than that for the anti-N of DcCoV UAE-HKU23.
Similarly, the antibody titer of the serum obtained from the mouse immunized with the recombinant
N protein of DcCoV UAE-HKU23 for the anti-N of DcCoV UAE-HKU23 was 32 folds higher than
that for the anti-N of MERS-CoV. Furthermore, for the mice immunized with heat-inactivated DcCoV
UAE-HKU23, the neutralization antibody titer against DcCoV UAE-HKU23 was at least 16 folds
higher than that against MERS-CoV. All these results confirmed that there is minimal serological
cross-reactivity among CoVs of different lineages in Betacoronavirus, supporting their classification as
separate lineages under Betacoronavirus.
A high seroprevalence for DcCoV UAE-HKU23 was observed in dromedaries. Since dromedaries
are the natural reservoirs of both DcCoV UAE-HKU23 and MERS-CoV, the seroprevalence of these
CoVs can only be ascertained if there is minimal serological cross-reactivity between these two viruses.
Based on the minimal serological cross-reactivity between DcCoV UAE-HKU23 and MERS-CoV shown
in the present study, we confirmed a high seroprevalence for DcCoV UAE-HKU23 in dromedaries as
determined by immunofluorescence antibody tests and neutralization antibody assays. The relatively
lower seropositivity as determined by Western blot in our previous study as compared to the very high
seropositivity as determined by immunofluorescence antibody tests and neutralization antibody assays
in the present study is because only prominent immunoreactive bands were considered unambiguously
positive in Western blot analysis and hence might have underestimated the true seroprevalence [50].
4. Materials and Methods
4.1. Virus Culture
Original fecal samples from all the 14 dromedaries tested positive for DcCoV UAE-HKU23
by RT-PCR [50] were subject to virus isolation in HRT-18G (human rectal tumor epithelial), RK13
(rabbit kidney), MDCK (canine kidney), MDBK (bovine kidney), Dubca (Dubai camel fetus skin
fibroblast), Caki-3-R (camel kidney), and BSC-1 (African green monkey renal epithelial) cells as
described previously [65]. Cell lines were prepared in culture plates and inoculated with 200 µL
of fecal samples diluted at 1:10. Non-attached viruses were removed by washing the cells twice in
phosphate-buffered saline. The monolayer cells were maintained in serum-free minimal essential
medium (MEM, Invitrogen, Carlsbad, CA, USA) with or without supplementation by tosylsulfonyl
phenylalanyl chloromethyl ketone (TPCK)-treated trypsin (1 µg/mL) (Sigma, St. Louis, MO, USA). All
infected cell lines were incubated at 37 ˝C for seven days. CPEs were examined at day 1, 3, 5, and 7 by
inverted light microscopy.
4.2. Real-Time Quantitative RT-PCR
The assay was performed using a real-time one-step qRT-PCR with DcCoV UAE-HKU23 primers
51-ATAGCGGCTACACGTGGTGTT-31 and 51-TCCCAGCCGCCATAAAACT-31 and probe 51-(FAM)
CTGTTGTTATAGGCACCACT (BHQ1)-31. To generate calibration curves, we prepared a series of six
log10 dilutions equivalent to 101–106 copies per reaction mixture and ran them in parallel with the
test samples.
4.3. Electron Microscopy
Negative contrast electron microscopy was performed as described previously [66,67]. Tissue
culture cell extracts infected with DcCoV UAE-HKU23 were centrifuged at 19,000ˆ g at 4 ˝C, after
which the pellet was resuspended in phosphate-buffered saline and stained with 2% phosphotungstic
acid. Samples were examined with a Philips EM208s electron microscope (Royal Philips, Amsterdam,
The Netherlands).
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4.4. Northern Blotting
Total RNA was extracted from DcCoV UAE-HKU23-infected HRT-18G cells using TRIzol Reagent
(Invitrogen, Carlsbad, CA, USA). RNA was separated on 1% agarose gel with 7% formaldehyde at
100 V in 1ˆ 3-(N-morpholino)propanesulfonic acid (MOPS) buffer (20 mM MOPS, 5 mM sodium
acetate, 1 mM EDTA), transferred to a positively charged nylon membrane (Roche Diagnostics,
Basel, Switzerland) with Transfer Buffer (Ambion, Foster City, CA, USA) by means of capillary
force for 2 h, cross-linked to the membrane by ultraviolet light (120 mJ/cm2) and baked at 80 ˝C
for 1 h. The blot was prehybridized with ULTRAhyb-Oligo Hybridization buffer (Ambion,
USA) and probed with a DcCoV UAE-HKU23 nucleocapsid-specific oligodeoxynucleotide probe
51-CCAGAACGATTTCCAGAGGACGCTCTACT-31, which was labeled with digoxigenin (DIG) at
31 end. The blot was hybridized at 42 ˝C overnight and washed with low- and high-stringency
buffers as recommended by the manufacturer (Ambion). Detection of DIG-labeled probe on the
blot was performed using DIG Luminescent Detection Kit according to manufacturer’s protocol
(Roche Diagnostics).
4.5. Determination of Leader-Body Junction Sequence
To determine the location of the leader and body TRSs used for DcCoV UAE-HKU23 mRNA
synthesis, the leader-body junction sites and flanking sequences of all DcCoV UAE-HKU23 subgenomic
mRNAs were determined using RT-PCR as described previously [56,68]. Briefly, intracellular RNA
was extracted from DcCoV UAE-HKU23-infected HRT-18G cells using TRIzol Reagent (Invitrogen).
Reverse transcription was performed using random hexamers and the SuperScript III kit (Invitrogen).
cDNA was PCR amplified with a forward primer located in the leader sequence and a reverse primer
located in the body of each mRNA (Table 2). The PCR mixture (25 µL) contained cDNA, PCR buffer
(10 mM Tris-HCl pH 8.3, 50 mM KCl, 2 mM MgCl2, and 0.01% gelatin), 200 µM of each dNTPs,
and 1.0 U Taq polymerase (Applied Biosystems, Foster City, CA, USA). The mixtures were amplified
in 40 cycles of 94 ˝C for 1 min, 50 ˝C for 1 min, and 72 ˝C for 1 min, and a final extension at 72 ˝C
for 10 min in an automated thermal cycler (Applied Biosystems). RT-PCR products corresponding to
each subgenomic mRNA could be distinguished by size differences on agarose gel electrophoresis.
PCR products were gel-purified using QIAquick gel extraction kit (QIAGEN, Hilden, Germany) and
sequenced to obtain the leader-body junction sequences for each subgenomic mRNA.
Table 2. Primers used for RT-PCR amplification of the leader-body junction of subgenomic mRNAs (sg
mRNAs) of dromedary camel coronavirus UAE-HKU23.
Primer Sequence (51-31) Use
LPW25800 GATTGTGAGCGATTTGCGTGC Forward primer for all sg mRNAs PCR
LPW18463 GTAAACCTTTATAATTTAACACA Reverse primer for mRNA (NS2) PCR
LPW25801 AATCGGTAAAGTGAAAACTCC Reverse primer for mRNA (HE) PCR
LPW25802 CCACAATGTACTCAACAATAAAG Reverse primer for mRNA (S) PCR
LPW25803 TAGCGAATGCTGTAAAACCAG Reverse primer for mRNA (NS5) PCR
LPW25804 CTCATAAAACTGCCTACCTCT Reverse primer for mRNA (E) PCR
LPW18468 CCAAGATACACATTATTCAACG Reverse primer for mRNA (M) PCR
LPW18469 GAGTAATTCCAGAGAACCAAGA Reverse primer for mRNA (N) PCR
4.6. Immunofluorescence Antibody Tests
HRT-18G cells infected with DcCoV UAE-HKU23 were fixed in chilled acetone at ´20 ˝C
for 10 min. The fixed cells were incubated with four-fold dilutions of serum from 1:10 to 1:10,240
from 59 dromedaries, followed by 1:50 diluted Novex FITC-goat anti-llama IgG (Invitrogen). Cells
were then examined under a fluorescence microscope. Uninfected cells were used as negative control.
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4.7. Neutralization Antibody Assays
Neutralization antibody assays for DcCoV UAE-HKU23 were carried out according to previously
described protocols with modifications [11,23]. Heat inactivated serum samples from dromedaries
were serially diluted from 1:10 and then mixed with 100 50% tissue culture infective dose (TCID50) of
DcCoV UAE-HKU23 isolate 263F. Available sera from 59 dromedaries were included. After incubation
for 2 h at 37 ˝C, the mixture was inoculated in duplicate on to 96-well plates of HRT-18G cell cultures.
Results were recorded after six days incubation at 37 ˝C.
4.8. Cloning and Purification of (His)6-Tagged Recombinant DcCoV UAE-HKU23 and MERS-CoV
Nucleocapsid Proteins from Escherichia coli
To produce two plasmids for DcCoV UAE-HKU23 and MERS-CoV N proteins purification,
primers (51-CATGCCATGGGCATGTCTTTTACTCCTGGTAAGC-31 and 51-CCGCTCGAGTATTTCT
GAGGTGTTTTCAG-31 for DcCoV UAE-HKU23 and 51-GGAATTCCATATGATGGCATCCCCTGC
TGCACCTC-31 and 51-ATAAGAATGCGGCCGCATCAGTGTTAACATCAATCATT-31 for MERS-CoV)
were used to amplify the genes encoding the N genes of DcCoV UAE-HKU23 and MERS-CoV,
respectively. The sequences encoding amino acids 1–449 and 1–414 of the N proteins of DcCoV
UAE-HKU23 and MERS-CoV respectively were amplified and cloned into the NcoI and XhoI
sites of expression vector pET-28b(+) and NdeI and NotI sites of expression vector pETH,
respectively (Novagen, Madison, WI, USA). The recombinant N proteins of DcCoV UAE-HKU23 and
MERS-CoV were expressed and purified using Ni2+-loaded HiTrap Chelating System (GE Healthcare,
Buckinghamshire, UK) according to the manufacturer’s instructions.
4.9. Animal Immunization Using N Proteins of DcCoV UAE-HKU23 and MERS-CoV
To prepare antibodies specific against the N proteins of DcCoV UAE-HKU23 and MERS-CoV
respectively, 30 µg of purified (His)6-tagged recombinant N proteins of DcCoV UAE-HKU23 or
MERS-CoV was mixed with an equal part of complete Freund’s adjuvant and injected subcutaneously
into balb/c (H-2d) mice (six to eight weeks old, 18 to 22 g). Incomplete Freund’s adjuvant was used
in subsequent injections. Serum samples were taken two weeks after the third injection for Western
blot analysis.
4.10. Western Blot Analysis
Western blot analysis was performed according to our published protocol [15], with 1.5 µg purified
(His)6-tagged recombinant N proteins of DcCoV UAE-HKU23 and MERS-CoV, respectively. Serum
samples of mice were titrated with serial two-fold dilutions, beginning at 1:2000. Antigen-antibody
interaction was detected with 1:4000 diluted horseradish peroxidase-conjugated goat anti-mouse IgG
(Novex, San Diego, CA, USA) and ECL fluorescence system (GE Healthcare, Buckinghamshire, UK).
4.11. Animal Immunization Using Heat-Inactivated DcCoV UAE-HKU23
DcCoV UAE-HKU23 was cultured in HRT-18G cells using serum-free MEM for four days and
was heat-inactivated at 60 ˝C for 1 h. The cells were frozen and thawed once. The cell debris was
removed by centrifugation and the supernatant was titrated and six balb/c mice were inoculated
intraperitoneally using 1 ˆ 105 TCID50 of heat-inactivated DcCoV UAE-HKU23. Three boosters were
administered on days 10, 20, and 30, respectively, with the heat inactivation of DcCoV UAE-HKU23
carried out on the day of injection. Serum samples were obtained 14 days after the fourth injection. The
sera from the six mice were pooled and neutralization antibody assay for DcCoV UAE-HKU23 was
performed as described above and that for MERS-CoV was performed as we described previously [69].
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4.12. Sequencing of Complete RdRp, S, and N Genes of DcCoV UAE-HKU23 Strains
Viral RNA was extracted from the fecal samples using EZ1 Virus Mini Kit v2.0 (QIAGEN). The
RNA was eluted in 60 µL of AVE buffer (QIAGEN) and was used as the template for RT-PCR.
The complete RdRp, S, and N genes of DcCoV UAE-HKU23 strains from 11 additional
dromedaries were amplified and sequenced using primers designed by multiple alignments of the
three complete genome sequences of DcCoV UAE-HKU23 [50]. Reverse transcription was performed
using the SuperScript III kit. The PCR mixture (25 µL) contained DNA, iProof High-fidelity PCR buffer
(Bio-Rad, Hercules, CA, USA), 200 µM of each dNTP, and 0.5 U iProof High-fidelity DNA polymerase
(Bio-Rad). The mixtures were amplified by using 40 cycles of 98 ˝C for 10 s, 55 ˝C for 30 s, and 72 ˝C
for 50 s, with a final extension at 72 ˝C for 10 min. Standard precautions were taken to avoid PCR
contamination and no false-positive was observed in negative controls.
The PCR products were gel-purified using the QIAquick gel extraction kit (QIAGEN). Both
strands of the PCR products were sequenced twice with an ABI Prism 3700 DNA Analyzer (Applied
Biosystems), using the PCR primers. The sequences of the PCR products were assembled manually.
4.13. Phylogenetic Analysis
The phylogenetic trees for RdRp, S, and N genes were constructed by the maximum likelihood
method using PhyML. The optimal model for the nucleotide sequences were determined using
ModelGenerator v85. The trees for RdRp and N genes were inferred by the GTR + I substitution model
and the tree for S gene was inferred by the GTR + I + G model.
4.14. Codon Usage Analysis and Genetic Distance of RdRp, S, and N Genes
The codon usage bias of the RdRp, S, and N genes of the members in Betacoronavirus 1 and
RbCoV HKU14 was estimated using RSCU. RSCU values were calculated for the 59 relevant codons
(excluding methionine, tryptophan, and stop codons) by SSE [70]. CA was performed on the RSCU
values using the R statistical software, version 2.15.1 [71] and the function “corresp” from the Modern
Applied Statistics with S (MASS) library. The SimPlot program (version 3.5.1) was used to analyze the
genetic distance of the RdRp, S, and N genes of DcCoV UAE-HKU23 and other wild ruminant CoVs
in reference to the RdRp, S, and N genes of alpaca CoV, and this genetic distance was plotted versus
nucleotide positions. The similarity plot was configured with window size: 200 nucleotides; step: 20;
F84 (maximum likelihood).
5. Conclusions
DcCoV UAE-HKU23 was successfully isolated in dromedary fecal samples using HRT-18G cells.
There was minimal serological cross-antigenicity between DcCoV UAE-HKU23 and MERS-CoV. DcCoV
UAE-HKU23 is a novel member of Betacoronavirus 1.
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